suramin has been researched along with Injury, Myocardial Reperfusion in 1 studies
Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine-enhanced IPC was inhibited by pretreatment with PTX and SPT but not by suramin or RB, whereas ATP-enhanced IPC was inhibited by suramin or RB in combination with PTX pretreatment." | 1.31 | Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors. ( Imamura, H; Kido, M; Lu, K; Ninomiya, H; Otani, H; Uchiyama, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ninomiya, H | 1 |
| Otani, H | 1 |
| Lu, K | 1 |
| Uchiyama, T | 1 |
| Kido, M | 1 |
| Imamura, H | 1 |
1 other study available for suramin and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors.
Topics: Adenosine; Adenosine Triphosphate; Animals; Enzyme Inhibitors; Genistein; GTP-Binding Proteins; Indo | 2002 |